The Bigger the Ship, the Harder It Is to Turn: Continued Clinical Inertia With SGLT2i Utilization in Heart Failure

被引：0
|
作者：
Lyle, Melissa [1 ]
Santos-Gallego, Carlos G. [2 ]
机构：
[1] Mayo Clin, Div Adv Heart Failure & Transplant Cardiol, Jacksonville, FL 32224 USA
[2] Icahn Sch Med Mt Sinai, Cardiovasc Inst, Athero Thrombosis Res Unit, New York, NY USA
来源：
JOURNAL OF CARDIAC FAILURE | 2024年 / 30卷 / 09期
关键词：
EMPAGLIFLOZIN; OUTCOMES;
D O I：
10.1016/j.cardfail.2024.05.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1098 / 1099
页数：2
相关论文
共 50 条
  • [41] UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
    Pugliese, R.
    Alcidi, G.
    Ioannoni, S.
    Diomede, D.
    Romano, M.
    Correale, M.
    Benvenuto, M.
    Gronda, E.
    Brunetti, N.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [42] A Quality Improvement Project of Increasing Utilization of SGLT2i in Patients With Heart Failure Within a Veterans Affairs Health System Through an Interdisciplinary Approach in the Primary Care Setting
    Baviriseaty, Niharika
    Parza, Kevin
    Gross, Cassandra
    Nehaul, Roger
    CIRCULATION, 2023, 148
  • [43] Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study
    Perez-Carrillo, Lorena
    Aragon-Herrera, Alana
    Gimenez-Escamilla, Isaac
    Delgado-Arija, Marta
    Garcia-Manzanares, Maria
    Anido-Varela, Laura
    Lago, Francisca
    Martinez-Dolz, Luis
    Portoles, Manuel
    Tarazon, Estefania
    Rosello-Lleti, Esther
    PHARMACEUTICS, 2022, 14 (10)
  • [44] Uptake of SGLT2i and Outcomes in Patients With Diabetes and Chronic Heart Failure: A Community-Based Cohort and a Specialized Clinic Cohort
    Gagnon, Luke R.
    Hazra, Deepan
    Perera, Kevin
    Wang, Kaiming
    Kashyap, Niharika
    Sadasivan, Chandu
    Chu, Luan Manh
    Dover, Doug
    Kaul, Padma
    Simpson, Scot
    Bello, Aminu
    Finlay, McAlister
    Oudit, Gavin Y.
    CIRCULATION, 2023, 148
  • [45] The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients-a retrospective study
    Zhu, Yi
    Zhang, Jia-li
    Jin, Hong
    Ji, Yuan
    Wang, Fang-fang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [46] Improving management of heart failure with reduced ejection fraction with sglt2i's by exploring practical considerations: an online education intervention
    Sattin, S.
    Sendaydiego, A. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 781 - 781
  • [47] Clinical pharmacology of SGLT-2 inhibitors in heart failure
    Velliou, Maria
    Polyzogopoulou, Effie
    Ventoulis, Ioannis
    Parissis, John
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (02) : 149 - 160
  • [48] SGLT2 inhibitors and heart failure - clinical implications
    Raz, Itamar
    Cahn, Avivit
    NATURE REVIEWS CARDIOLOGY, 2016, 13 (04) : 185 - 186
  • [49] SGLT2 inhibitors and heart failure — clinical implications
    Itamar Raz
    Avivit Cahn
    Nature Reviews Cardiology, 2016, 13 : 185 - 186
  • [50] Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i
    Lamacchia, Olga
    Sorrentino, Maria Rosaria
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (02) : 233 - 240
12345